Lacay, Elyza Suezanne E.
HRN: 25-84-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2024
AMPICILLIN 500MG (VIAL)
09/21/2024
09/27/2024
IV
130mg
Q12
Staphylococcal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes